Skip to main content
. 2020 Jul 12;132:150–157. doi: 10.1016/j.amjcard.2020.07.007

Table 2.

Symptoms reported in ACEI/ARB and non-ACEI/ARB groups before and after propensity score matching

Unmatched
Matched
ACEI/ARB Non-ACEI/ARB p value ACEI/ARB Non-ACEI/ARB p value
n = 78 n = 512 n = 78 n = 71
Symptoms
Fever 39 (62.9%) 310 (67.1%) 0.567 39 (61.9%) 44 (67.7%) 0.493
Cough 47 (77.1%) 364 (79.1%) 0.708 47 (75.8%) 48 (76.2%) 0.961
Sore throat 10 (16.1%) 124 (27.4%) 0.064 10 (16.1%) 12 (21.1%) 0.645
Congestion/Rhinorrhea 16 (28.1%) 160 (35.8%) 0.302 16 (28.1%) 17 (29.9%) 0.841
Dyspnea 28 (44.4%) 153 (33.4%) 0.091 28 (43.8%) 16 (25.4%) 0.041
Chest Pain 6 (10.1%) 74 (16.2%) 0.257 6 (9.8%) 10 (16.1%) 0.422
Dizziness 5 (9.1%) 24 (5.6%) 0.357 5 (8.9%) 2 (3.3%) 0.261
Syncope 2 (3.6%) 6 (1.4%) 0.225 3 (5.4%) 4 (6.7%) 0.982
Myalgias 28 (45.2%) 219 (47.9%) 0.787 28 (44.4%) 28 (45.2%) 0.936
Fatigue 21 (36.8%) 164 (36.3%) 0.934 21 (36.8%) 19 (31.1%) 0.563
Headache 7 (12.3%) 126 (28.1%) 0.011 7 (12.3%) 14 (23.3%) 0.151
Gastrointestinal symptoms 26 (42.6%) 179 (39.3%) 0.613 26 (42.6%) 20 (32.3%) 0.267
Altered mental status 4 (8.2%) 11 (2.9%) 0.081 5 (10.1%) 10 (18.9%) 0.267